Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: Results of the German IGLU follow-up study 2001

Human Reproduction

Volumn 20, Issue 5, 2005, Pages 1418-1421

  Doerr, Helmuth G ^a   Bettendorf, Markus ^c   Hauffa, Berthold P ^d   Mehls, Otto ^c   Partsch, Carl Joachim ^f   Said, Elfriede ^g   Sander, Sabine ^g   Schwarz, Hans Peter ^e   Stahnke, Nikolaus ^h   Steinkamp, Heiner ^g   Ranke, Michael B ^b   Akkurt, H I ⁱ   Andler, W ⁱ   Becker, M ⁱ   Bohles H J ⁱ   Bramswig J ⁱ   Butenandt, O ⁱ   Bettendorf, M ⁱ   Doerr, H G ⁱ   Ehrich, J H H ⁱ   Erxleben, B ⁱ   Griefahn, B ⁱ   Grueters, A ⁱ   Hartmann, K ⁱ   Hauffa, B P ⁱ   Haverkamp, F ⁱ   Hecker, W ⁱ   Heinrich, U ⁱ   Hinkel, G K ⁱ   Hiort, O ⁱ   Holl, R ⁱ   Homoki, J ⁱ   Horneff, G ⁱ   Irle, U ⁱ   Johs, R ⁱ   Jourdan, C ⁱ   Keller, E ⁱ   Kerstan, J ⁱ   Korsch, E ⁱ   Kreuder, J ⁱ   Krohn, H P ⁱ   Krull, F ⁱ   Kunze, D ⁱ   Lakomek, M ⁱ   Lenz, D ⁱ   Leuthold, U ⁱ   Mix, M ⁱ   Mohnike, K ⁱ   Morlot, M ⁱ   Muhlenberg R ⁱ   Muller H ⁱ   Partsch, C J ⁱ   Pavlovic, M ⁱ   Rager, K ⁱ   Ranke, M B ⁱ   Rauh, W ⁱ   Rickers, H J ⁱ   Schenk, B ⁱ   Schnabel, D ⁱ   Schonau E ⁱ   Schwarz, H P ⁱ   Skimic Schleicher, G ⁱ   Sippell, W G ⁱ   Stahnke, N ⁱ   Teufel, M ⁱ   Tillmann, W ⁱ   Tittel, B ⁱ   Tuschy, U ⁱ   Ullrich, K P ⁱ   von Petrikowsky, W ⁱ   Weber, H P ⁱ   Wesseler, K ⁱ   Willig, R P ⁱ   Wintgens, J ⁱ   Witsch, M ⁱ   more..

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g PFIZER INC   (United States)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ NONE

Author keywords

Estrogen therapy; Gonadal dysgenesis; Turner syndrome; Uterine size

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GROWTH HORMONE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BREAST DEVELOPMENT; CALCULATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DISEASE CLASSIFICATION; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GERMANY; GROWTH CURVE; HORMONAL THERAPY; HUMAN; KARYOTYPE 45,X; KARYOTYPE 46,XX; KARYOTYPE 46,XY; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; PUBERTY; SCORING SYSTEM; SIDE EFFECT; STANDARDIZATION; TURNER SYNDROME; UTERUS;

EID: 20344380670     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh764     Document Type: Article

References (17)

1. Bridges NA, Cooke A, Healy MJ et al. (1996) Growth of the uterus. Arch Dis Child 75,330-331.
2. Cacciari E and Mazzanti L (1999) Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy Italian Study Group for Turner Syndrome. J Clin Endocrinol Metab 84,4510-4515.
3. Chernausek SD, Attie KM, Cara JF et al. (2000) Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc, Collaborative Study Group. J Clin Endocrinol Metab 85,2439-2445.
4. Cohen HL and Haller JO (1989) Pediatric and Adolescent Genital Anormalities. In Babcock DS (ed.) Neonatal and Pediatric Ultrasonography. Churchill Livingstone, New York, pp. 187-215.
5. Haber HP and Ranke MB (1999) Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume. J Ultrasound Med 18, 271-276.
6. Massarano AA, Adams JA, Preece MA et al. (1989) Ovarian ultrasound appearances in Turner syndrome. J Pediatr 114,568-573.
7. Mazzanti L, Cacciari E, Bergamaschi R et al. (1997) Pelvic ultrasonography in patients with Turner syndrome: age-related findings in different karyotypes. J Pediatr 131,135-140.
8. McDonnell CM, Coleman L and Zacharin MR (2003) A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound. Clin Endocrinol (Oxf) 58,446-450.
9. Paterson WF, Hollman AS and Donaldson MD (2002) Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol (Oxf) 56,359-365.
10. Pelzer V (1991) [The value of ultrasonography in pediatric and adolescent gynecology]. Gynakologe 24,91-96.
11. Ranke MB, Stubbe P, Majewski F et al. (1988) Spontaneous growth in Turner's syndrome. Acta Paediatr Scand Suppl 343,22-30.
12. Ranke MB, Lindberg A, Chatelain P et al. (2000) Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models KIGS International Board Kabi International Growth Study. J Clin Endocrinol Metab 85, 4212-4218.
13. Ranke MB, Partsch CJ, Lindberg A et al. (2002) Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 147,625-633.
14. Sampaolo P, Calcaterra V, Klersy C et al. (2003) Pelvic ultrasound evaluation in patients with Turner syndrome during treatment with growth hormone. Ultrasound Obstet Gynecol 22,172-177.
15. Shawker TH, Garra BS, Loriaux DL et al. (1986) Ultrasonography of Turner's syndrome. J Ultrasound Med 5,125-129.
16. Snajderova M, Mardesic T, Lebl J et al. (2003) The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 60,198-204.
17. Wilson CA, Heinrichs C, Larmore KA et al. (2003) Estradiol levels in girls with Turner's syndrome compared to normal prepubertal girls as determined by an ultrasensitive assay. J Pediatr Endocrinol Metab 16,91-96.